Abstract: Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
Type:
Grant
Filed:
November 4, 2011
Date of Patent:
August 5, 2014
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Lu Shan, Michael Bethune, Chaitan Khosla, Jonathan Gass, Gail G. Pyle, Gary M. Gray, Indu Isaacs, Gregg Strohmeier